Antares pharma, inc. reports earnings results for the third quarter ended september 30, 2019

Antares pharma, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced total revenue was usd 34.306 million compared to usd 17.868 million a year ago. operating income was usd 1.996 million compared to operating loss of usd 1.359 million a year ago. net income was usd 1.043 million compared to net loss of usd 1.936 million a year ago. basic earnings per share was usd 0.01 compared to basic loss per share of usd 0.01 a year ago. for the nine months, total revenue was usd 86.025 million compared to usd 44.733 million a year ago. operating loss was usd 4.575 million compared to usd 10.889 million a year ago. net loss was usd 6.722 million compared to usd 12.649 million a year ago. basic loss per share was usd 0.04 compared to usd 0.08 a year ago.
ATRS Ratings Summary
ATRS Quant Ranking